Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann Et Al And
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40022
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2017
Authors
Publisher
Wiley